Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A- reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics

• Auteurs principaux: Ali Nosrati Andevari (Auteur), Soheila Moein (Auteur), Durdi Qujeq (Auteur), Zoleikha Moazezi (Auteur), Karimollah Hajian Tilaki (Auteur)
• Format: Livre
• Publié: Society of Diabetic Nephropathy Prevention, 2021-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Introduction: Atorvastatin hinders cardiovascular disease by reducing cholesterol levels. Proprotein convertase subtilisin/kexin type 9 (PCSK9) enhances the secretion of insulin by binding to LDL receptor. Sortilin is committed in the transfer of intracellular proteins through the plasma membrane. O...